APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Bioanalytical Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cell and Gene Therapy Bioanalytical Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17408765034 March 2026197 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Bioanalytical Testing Services Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Bioanalytical Testing Services Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Bioanalytical Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Bioanalytical Testing Services Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Bioanalytical Testing Services Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Bioanalytical Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cell and Gene Therapy Bioanalytical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy Bioanalytical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy Bioanalytical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cell and Gene Therapy Bioanalytical Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cell and Gene Therapy Bioanalytical Testing Services include BioAgilytix Labs, KCAS Bioanalytical Services, Laboratory Corporation of America Holdings, Pharmaceutical Product Development, Inc., Prolytix, Pharmaron, Charles River Laboratories, Syneos Health and SGS SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cell and Gene Therapy Bioanalytical Testing Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell and Gene Therapy Bioanalytical Testing Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell and Gene Therapy Bioanalytical Testing Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell and Gene Therapy Bioanalytical Testing Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell and Gene Therapy Bioanalytical Testing Services Segment by Company

BioAgilytix Labs

KCAS Bioanalytical Services

Laboratory Corporation of America Holdings

Pharmaceutical Product Development, Inc.

Prolytix

Pharmaron

Charles River Laboratories

Syneos Health

SGS SA

CD BioSciences

Cell and Gene Therapy Bioanalytical Testing Services Segment by Type

Gene Therapy

Gene-modified Cell Therapy

Cell Therapy

Cell and Gene Therapy Bioanalytical Testing Services Segment by Application

Non-clinical Contract Manufacturing Organizations

Pharma and Biopharma Companies

Contract Research Organizations

Others

Cell and Gene Therapy Bioanalytical Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Bioanalytical Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Bioanalytical Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Bioanalytical Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell and Gene Therapy Bioanalytical Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy Bioanalytical Testing Services industry.

Chapter 3: Detailed analysis of Cell and Gene Therapy Bioanalytical Testing Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy Bioanalytical Testing Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Gene Therapy Table 3. Key Players of Gene-modified Cell Therapy Table 4. Key Players of Cell Therapy Table 4. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Non-clinical Contract Manufacturing Organizations Table 6. Key Players of Pharma and Biopharma Companies Table 7. Key Players of Contract Research Organizations Table 8. Key Players of Others Table 9. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Region (2021-2026) Table 12. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Region (2027-2032) Table 14. Cell and Gene Therapy Bioanalytical Testing Services Industry Trends Table 15. Cell and Gene Therapy Bioanalytical Testing Services Industry Drivers Table 16. Cell and Gene Therapy Bioanalytical Testing Services Industry Opportunities and Challenges Table 17. Cell and Gene Therapy Bioanalytical Testing Services Industry Restraints Table 18. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Company (2021-2026) Table 20. Global Cell and Gene Therapy Bioanalytical Testing Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell and Gene Therapy Bioanalytical Testing Services Key Company Head Office and Area Served Table 22. Global Cell and Gene Therapy Bioanalytical Testing Services Company, Product Type & Application Table 23. Global Cell and Gene Therapy Bioanalytical Testing Services Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell and Gene Therapy Bioanalytical Testing Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Type (2021-2026) Table 30. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Type (2027-2032) Table 31. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2021-2026) Table 35. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2027-2032) Table 36. BioAgilytix Labs Company Information Table 37. BioAgilytix Labs Business Overview Table 38. BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 40. BioAgilytix Labs Recent Development Table 41. KCAS Bioanalytical Services Company Information Table 42. KCAS Bioanalytical Services Business Overview Table 43. KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 45. KCAS Bioanalytical Services Recent Development Table 46. Laboratory Corporation of America Holdings Company Information Table 47. Laboratory Corporation of America Holdings Business Overview Table 48. Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 50. Laboratory Corporation of America Holdings Recent Development Table 51. Pharmaceutical Product Development, Inc. Company Information Table 52. Pharmaceutical Product Development, Inc. Business Overview Table 53. Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 55. Pharmaceutical Product Development, Inc. Recent Development Table 56. Prolytix Company Information Table 57. Prolytix Business Overview Table 58. Prolytix Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Prolytix Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 60. Prolytix Recent Development Table 61. Pharmaron Company Information Table 62. Pharmaron Business Overview Table 63. Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 65. Pharmaron Recent Development Table 66. Charles River Laboratories Company Information Table 67. Charles River Laboratories Business Overview Table 68. Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 70. Charles River Laboratories Recent Development Table 71. Syneos Health Company Information Table 72. Syneos Health Business Overview Table 73. Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 75. Syneos Health Recent Development Table 76. SGS SA Company Information Table 77. SGS SA Business Overview Table 78. SGS SA Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. SGS SA Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 80. SGS SA Recent Development Table 81. CD BioSciences Company Information Table 82. CD BioSciences Business Overview Table 83. CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio Table 85. CD BioSciences Recent Development Table 86. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026) Table 92. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032) Table 93. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026) Table 99. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032) Table 100. China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026) & (US$ Million) Table 101. China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032) & (US$ Million) Table 102. China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026) & (US$ Million) Table 103. China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026) Table 110. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Bioanalytical Testing Services Product Image Figure 2. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type: 2025 VS 2032 Figure 4. Gene Therapy Image Figure 5. Gene-modified Cell Therapy Image Figure 6. Cell Therapy Image Figure 7. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application: 2025 VS 2032 Figure 9. Non-clinical Contract Manufacturing Organizations Image Figure 10. Pharma and Biopharma Companies Image Figure 11. Contract Research Organizations Image Figure 12. Others Image Figure 13. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 15. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Cell and Gene Therapy Bioanalytical Testing Services Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Cell and Gene Therapy Bioanalytical Testing Services Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Type (2021-2032) Figure 22. Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Cell and Gene Therapy Bioanalytical Testing Services Revenue Market Share by Application (2021-2032) Figure 24. North America Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 25. North America Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032) Figure 26. North America Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032) Figure 27. North America Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032) Figure 28. United States Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 29. Canada Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 31. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 32. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032) Figure 33. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032) Figure 34. Europe Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032) Figure 35. Germany Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 36. France Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 38. Italy Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 39. Russia Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 41. China Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 42. China Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032) Figure 43. China Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032) Figure 44. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 45. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032) Figure 46. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032) Figure 47. Asia Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032) Figure 48. Japan Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 52. India Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 53. Australia Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032) Figure 58. Brazil Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 63. UAE Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 65. Chile Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Gene-modified Cell Therapy
  • Cell Therapy
Applications
  • Non-clinical Contract Manufacturing Organizations
  • Pharma and Biopharma Companies
  • Contract Research Organizations
  • Others
Companies covered
  • BioAgilytix Labs
  • KCAS Bioanalytical Services
  • Laboratory Corporation of America Holdings
  • Pharmaceutical Product Development, Inc.
  • Prolytix
  • Pharmaron
  • Charles River Laboratories
  • Syneos Health
  • SGS SA
  • CD BioSciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Therapy
  5. 1.2.3 Gene-modified Cell Therapy
  6. 1.2.4 Cell Therapy
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Non-clinical Contract Manufacturing Organizations
  10. 1.3.3 Pharma and Biopharma Companies
  11. 1.3.4 Contract Research Organizations
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Cell and Gene Therapy Bioanalytical Testing Services Growth Trends by Region
  15. 1.5.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2021-2026)
  17. 1.5.3 Cell and Gene Therapy Bioanalytical Testing Services Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Cell and Gene Therapy Bioanalytical Testing Services Market Dynamics
  1. 2.1 Cell and Gene Therapy Bioanalytical Testing Services Industry Trends
  2. 2.2 Cell and Gene Therapy Bioanalytical Testing Services Industry Drivers
  3. 2.3 Cell and Gene Therapy Bioanalytical Testing Services Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Bioanalytical Testing Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cell and Gene Therapy Bioanalytical Testing Services Revenue by Company (2021-2026)
  2. 3.2 Global Cell and Gene Therapy Bioanalytical Testing Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cell and Gene Therapy Bioanalytical Testing Services Key Company Head office and Area Served
  4. 3.4 Global Cell and Gene Therapy Bioanalytical Testing Services Company, Product Type & Application
  5. 3.5 Global Cell and Gene Therapy Bioanalytical Testing Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cell and Gene Therapy Bioanalytical Testing Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cell and Gene Therapy Bioanalytical Testing Services Tier 1, Tier 2, and Tier 3
4 Cell and Gene Therapy Bioanalytical Testing Services Market by Type
  1. 4.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2032)
  3. 4.3 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Share by Type (2021-2032)
5 Cell and Gene Therapy Bioanalytical Testing Services Market by Application
  1. 5.1 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2032)
  3. 5.3 Global Cell and Gene Therapy Bioanalytical Testing Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 BioAgilytix Labs
  2. 6.1.1 BioAgilytix Labs Company Information
  3. 6.1.2 BioAgilytix Labs Business Overview
  4. 6.1.3 BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 BioAgilytix Labs Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  6. 6.1.5 BioAgilytix Labs Recent Developments
  7. 6.2 KCAS Bioanalytical Services
  8. 6.2.1 KCAS Bioanalytical Services Company Information
  9. 6.2.2 KCAS Bioanalytical Services Business Overview
  10. 6.2.3 KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 KCAS Bioanalytical Services Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  12. 6.2.5 KCAS Bioanalytical Services Recent Developments
  13. 6.3 Laboratory Corporation of America Holdings
  14. 6.3.1 Laboratory Corporation of America Holdings Company Information
  15. 6.3.2 Laboratory Corporation of America Holdings Business Overview
  16. 6.3.3 Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Laboratory Corporation of America Holdings Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  18. 6.3.5 Laboratory Corporation of America Holdings Recent Developments
  19. 6.4 Pharmaceutical Product Development, Inc.
  20. 6.4.1 Pharmaceutical Product Development, Inc. Company Information
  21. 6.4.2 Pharmaceutical Product Development, Inc. Business Overview
  22. 6.4.3 Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pharmaceutical Product Development, Inc. Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  24. 6.4.5 Pharmaceutical Product Development, Inc. Recent Developments
  25. 6.5 Prolytix
  26. 6.5.1 Prolytix Company Information
  27. 6.5.2 Prolytix Business Overview
  28. 6.5.3 Prolytix Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Prolytix Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  30. 6.5.5 Prolytix Recent Developments
  31. 6.6 Pharmaron
  32. 6.6.1 Pharmaron Company Information
  33. 6.6.2 Pharmaron Business Overview
  34. 6.6.3 Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pharmaron Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  36. 6.6.5 Pharmaron Recent Developments
  37. 6.7 Charles River Laboratories
  38. 6.7.1 Charles River Laboratories Company Information
  39. 6.7.2 Charles River Laboratories Business Overview
  40. 6.7.3 Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Charles River Laboratories Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  42. 6.7.5 Charles River Laboratories Recent Developments
  43. 6.8 Syneos Health
  44. 6.8.1 Syneos Health Company Information
  45. 6.8.2 Syneos Health Business Overview
  46. 6.8.3 Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Syneos Health Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  48. 6.8.5 Syneos Health Recent Developments
  49. 6.9 SGS SA
  50. 6.9.1 SGS SA Company Information
  51. 6.9.2 SGS SA Business Overview
  52. 6.9.3 SGS SA Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 SGS SA Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  54. 6.9.5 SGS SA Recent Developments
  55. 6.10 CD BioSciences
  56. 6.10.1 CD BioSciences Company Information
  57. 6.10.2 CD BioSciences Business Overview
  58. 6.10.3 CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 CD BioSciences Cell and Gene Therapy Bioanalytical Testing Services Product Portfolio
  60. 6.10.5 CD BioSciences Recent Developments
7 North America
  1. 7.1 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032)
  2. 7.2 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type
  3. 7.2.1 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032)
  6. 7.3 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application
  7. 7.3.1 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032)
  10. 7.4 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country
  11. 7.4.1 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032)
  2. 8.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type
  3. 8.2.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032)
  6. 8.3 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application
  7. 8.3.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032)
  10. 8.4 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country
  11. 8.4.1 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032)
  2. 9.2 China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type
  3. 9.2.1 China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026)
  4. 9.2.2 China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032)
  5. 9.2.3 China Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032)
  6. 9.3 China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application
  7. 9.3.1 China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026)
  8. 9.3.2 China Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032)
  9. 9.3.3 China Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032)
  2. 10.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type
  3. 10.2.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032)
  6. 10.3 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application
  7. 10.3.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032)
  10. 10.4 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country
  11. 10.4.1 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cell and Gene Therapy Bioanalytical Testing Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst